What is the CVSS score of CVE-2026-21970?

CVE-2026-21970 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.0%.

Which versions of Life Sciences Central Designer are affected by CVE-2026-21970?

CVE-2026-21970 presents notable security risk rated CVSS 6.5. Exploitation could compromise the security of affected deployments.

How to fix or mitigate CVE-2026-21970?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Life Sciences Central Designer CVE-2026-21970

MEDIUM

2026-01-20 secalert_us@oracle.com

Oracle Life Sciences Central Designer

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 12, 2026 - 21:54 vuln.today

CVE Published

Jan 20, 2026 - 22:16 nvd

MEDIUM 6.5

DescriptionCVE.org

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

AnalysisAI

Life Sciences Central Designer versions up to 7.0.1.0 contains a vulnerability that allows attackers to unauthorized access to critical data or complete access to all Oracle Life Scien (CVSS 6.5).

Technical ContextAI

affects Life Sciences Central Designer. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible dat